GLP-1 receptor agonists like semaglutide reduce appetite and promote weight loss, but approximately 25-30% of weight loss can come from lean muscle tissue if proper countermeasures aren't taken
Diabetes and obesity, two conditions often treated with Tirzepatide, are major risk factors for kidney disease
W zmieniajcym si krajobrazie farmakoterapii metabolicznej, trwajce globalne badania stale pogbiaj nasz wiedz na temat terapii opartych na inkretynach
How Each Tanning Peptide Works in the Body Both Melanotan I and II are designed to mimic MSH, binding to melanocortin receptors on melanocytes in the skin
T-bet + CD11c + B cells are critical for antichromatin immunoglobulin G production in the development of lupus
Save The GLP-1 story has been hard to miss this year, and at ACR Convergence, its clear that these drugs are starting to make real waves in rheumatology